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ORIGINAL ARTICLE
In Vivo Evaluation of Adipose-Derived Stromal Cells
Delivered with a Nanofiber Scaffold
for Tendon-to-Bone Repair
Justin Lipner, PhD,1,2 Hua Shen, PhD,1 Leonardo Cavinatto, MD,1 Wenying Liu, PhD,3
Necat Havlioglu, MD,4 Younan Xia, PhD,5 Leesa M. Galatz, MD,1 and Stavros Thomopoulos, PhD6
Rotator cuff tears are common and cause a great deal of lost productivity, pain, and disability. Tears are
typically repaired by suturing the tendon back to its bony attachment. Unfortunately, the structural (e.g., aligned
collagen) and compositional (e.g., a gradient in mineral) elements that produce a robust attachment in the
healthy tissue are not regenerated during healing, and the repair is prone to failure. Two features of the failed
healing response are deposition of poorly aligned scar tissue and loss of bone at the repair site. Therefore, the
objective of the current study was to improve tendon-to-bone healing by promoting aligned collagen deposition
and increased bone formation using a biomimetic scaffold seeded with pluripotent cells. An aligned nanofibrous
poly(lactic-co-glycolic acid) scaffold with a gradient in mineral content was seeded with adipose-derived
stromal cells (ASCs) and implanted at the repair site of a rat rotator cuff model. In one group, cells were
transduced with the osteogenic factor bone morphogenetic protein 2 (BMP2). The healing response was
examined in four groups (suture only, acellular scaffold, cellular scaffold, and cellular BMP2 scaffold) using
histologic, bone morphology, and biomechanical outcomes at 14, 28, and 56 days. Histologically, the healing
interface was dominated by a fibrovascular scar response in all groups. The acellular scaffold group showed a
delayed healing response compared to the other groups. When examining bone morphology parameters, bone
loss was evident in the cellular BMP2 group compared to other groups at 28 days. When examining repair-site
mechanical properties, strength and modulus were decreased in the cellular BMP2 groups compared to other
groups at 28 and 56 days. These results indicated that tendon-to-bone healing in this animal model was
dominated by scar formation, preventing any positive effects of the implanted biomimetic scaffold. Further-
more, cells transduced with the osteogenic factor BMP2 led to impaired healing, suggesting that this growth
factor should not be used in the tendon-to-bone repair setting.
Introduction
Rotator cuff tears are common, particularly in theaging population, and lead to significant lost produc-
tivity, pain, and disability. In the United States, *600,000
patients require rotator cuff-related surgery each year.1
Unfortunately, a large number of surgical repairs fail, even
in the young and healthy patient population.2 At the root of
these failures is a healing process of tendon to bone that
does not regenerate the original tissue and is characterized
by bone loss and scar formation.3 At the healing interface, a
lack of graded mineral content and poorly organized colla-
gen fibers result in a mechanically weak attachment.4,5 The
poor results after rotator cuff repair in the clinical popula-
tion motivate the need for novel approaches to enhance
healing and improve outcomes.
Two key features of poor healing, and hence therapeutic
targets, are mineral loss in the bone adjacent to the tendon
attachment and poorly organized collagen deposition at the
repair site.6,7 Bone loss is a well-described outcome of
tendon-to-bone healing. Loss of bone occurs after tendon and
ligament tears, presumably due to the loss of mechanical
loading.8 However, significant bone loss is also apparent
when surgical repair is performed soon after injury.6 This
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post-repair bone loss is thought to be the result of increased
osteoclast activity in the bone directly adjacent to the at-
tachment.9 Furthermore, suppression of bone resorption re-
sults in improved healing.10 Less is known about the effect
of bone anabolic agents (e.g., bone morphogenetic protein 2
[BMP2]) on tendon-to-bone healing.11,12 A second feature of
tendon-to-bone healing is the deposition of disorganized
extracellular matrix rather than the well-aligned collagen
fibers found in native tendon.7 This scar tissue is an order-of-
magnitude weaker than the uninjured tissue and is not well
integrated into the bone.7 Enhanced bone formation and
aligned collagen deposition integrating across the attachment
would greatly enhance the strength of the healing interface.
Based on these prior observations, the goal of the current
study was to enhance tendon-to-bone healing by delivery of
an aligned biomimetic scaffold with pluripotent cells and an
osteogenic factor (BMP2) to the repair site. This scaffold
mimicked two features that are critical to the mechanics of
the natural tendon-to-bone attachment: aligned fibers and a
gradient in mineral content.13,14 In support of this approach,
in vitro experiments showed that a gradient in mineral led to
a gradient in osteogenesis by adipose-derived stromal cells
(ASCs).15 We hypothesized that (i) aligned nanofibers would
guide deposition of aligned collagen, (ii) a mineral gradient
would promote graded differentiation of the implanted
stromal cells, and (iii) BMP2 would promote osteogenesis
and bone formation at the repair site. The combination of
improved collagen orientation and increased bone formation
was expected to result in a stronger and tougher tendon-to-
bone repair.
Materials and Methods
Study design
To examine the effects of scaffold characteristics (align-
ment and mineral content), ASCs, and BMP2 on tendon-to-
bone healing, four groups were examined in a rat rotator
cuff injury and repair model: suture repair (i.e., without
ASCs or scaffold), acellular scaffold (i.e., repair with scaf-
fold, but without ASCs), cellular scaffold (i.e., repair with
ASC-seeded scaffold), and cellular BMP2 scaffold (i.e.,
repair with BMP2-transduced ASC-seeded scaffold). Re-
pairs were evaluated at 14, 28, and 56 days for histologic,
morphologic, and biomechanical outcomes.
Cell-seeded layered scaffold
A multilayered scaffold was used to deliver structural
(i.e., aligned nanofibers), compositional (i.e., spatial gradi-
ent in mineral), and biologic (i.e., BMP2 produced by
ASCs) cues to the repair site. This layered design followed a
similar approach previously developed for flexor tendon
repair.16 The implanted scaffold had five layers: three sheets
of poly(lactic-co-glycolic acid) (PLGA) nanofibers with
gradients in mineral with two layers of fibrin matrix between
them. The fibrin provided a rapidly resorbed layer with a
large enough volume to deliver cells to the repair site.
PLGA nanofiber mat with spatial gradient of mineral con-
tent. Nonwoven mats of nanofibers were generated by
electrospinning PLGA (85:15 lactic:glycolic ratio; Sigma,
St. Louis, MO) onto conducting collectors, as described
previously.14 The fiber diameters were 400–900 nm (as
measured using scanning electron microscopy [SEM] im-
ages), and the fiber mats were *60-mm thick (as measured
by laser micrometer, LK-081; Keyence, Osaka, Japan). The
electrospun scaffolds were then mineralized with a gradient
in mineral by a 10 times simulated body fluid (10SBF).17 To
prepare the scaffolds for mineralization, the samples were
cut into pieces and mounted onto carbon tape-covered wire
frames. The mounted samples were then plasma treated for
8min to increase surface energy and hydrophillicity (PDC-
001; Harrick Plasma, Ithaca, NY).18 Scaffolds were soaked
in 10SBF without sodium bicarbonate for 30min to bind
calcium to the surface. The mounted samples were then
placed in glass vials and filled with 10SBF. A syringe pump
was used to fill the vials at a constant rate to create linear
gradients in immersion time and hence mineral content.14
SEM was used to verify the fiber and mineral morphol-
ogies. Samples were mounted on carbon tape-coated alu-
minum SEM posts and sputter coated with Au-Pd for*45 s
to allow a charge path for the primary electrons. Posts were
then imaged under high vacuum using an FEI Nova Nano-
SEM 2300 and accelerating voltages of between 5 and
10 kV. An energy-dispersive X-ray was performed using the
FEI Nova NanoSEM 2300 during SEM imaging to deter-
mine the spatial variation of mineral content along the
length of the scaffold. Moving in 1–2mm increments, re-
gions were assessed for their calcium and carbon atomic
content. Three regions were analyzed for each measurement
along the mineral gradient and averaged for atomic content.
Three 5- · 5-mm scaffold pieces were used to create the final
five-layer construct, as described previously.16 All scaffolds
had appropriate fiber diameters and mineral gradients,
consistent with our previous work.14
Fibrin hydrogel. Fibrin solution was prepared from
human fibrinogen (EMD Millipore, Billerica, MA) and
dissolved in tris-buffered saline at a concentration of 20mg/
mL. The fibrin solution was filtered and combined 1:1 with
three components to produce the polymerizing fibrin solu-
tion: 140 parts alpha-minimum essential medium, 55 parts
50mM CaCl2, and 5 parts 1000U/mL thrombin. Constructs
were assembled from three layers of PLGA, joined by two
layers of fibrin hydrogel that adhered the layers together and
provided volume to deliver a large amount of cells.16 Cel-
lular gels were created with identical fibrin mixed with 3.6
million cells. The final scaffolds measured roughly
5 · 5 · 1mm, leading to a cell concentration of *2 million
cells per milliliter (500,000 cells/scaffold).
Adipose-derived stromal cells. Allogeneic ASCs were
isolated from the subcutaneous adipose tissue of juvenile
male Sprague-Dawley rats. The tissue was digested using
0.2% collagenase A for 2 h, and the resulting cell solution
was passed through 70-mm filters, cultured, and selected for
plastic adherence. Cellular scaffolds were seeded with pas-
sage 3 cells overnight at a density of 35,000/cm2 before
implantation. These cells have been shown to be able to
differentiate into a wide variety of lineages, including te-
nocytes, chondrocytes, and osteoblasts.19,20
Generation and testing of human BMP2-yellow fluorescent
protein construct and adenovirus. For delivery of BMP2,
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cells were transduced with an adenovirus that leads them to
produce a BMP2-yellow fluorescent protein (YFP) fusion
protein. To create viral vectors, a human (h) BMP2 con-
struct (kindly provided by Dr. Su-Li Cheng at Washington
University in St. Louis) without a stop code was cloned into
a pCR2.1 vector by polymerase chain reaction (PCR)
cloning. To generate the recombinant hBMP2-YFP con-
struct, a YFP construct with a stop code at the 3¢ end of its
coding sequence and EcoRV and NotI restriction sites at its
5¢ and 3¢ ends, respectively, was generated by PCR and
cloned into pCR2.1-hBMP2 vector at EcoRV and NotI sites,
with its 5¢ end in frame with the hBMP2 coding sequence.
The resulting hBMP2-YFP construct was subsequently
cloned into a pVQpacAd5CMVK-NpA shuttle vector
(ViraQuest, Inc., North Liberty, IA) at KpnI and NotI sites.
The hBMP2-YFP adenovirus was commercially prepared
and purified to 5 · 1010 plaque-forming units/mL (Vira-
Quest). Titration tests were used to test the effectiveness of
different vector concentrations (0, 0.25, 0.5, 1, 2, 4 mL of
vector solution) and changes in BMP2 expression over time
(Supplementary Fig. S1; Supplementary Data are available
online at www.liebertpub.com/tea). Based on these in vitro
studies, 4 mL vector per 500,000 cells concentration and 3
days of culture were chosen for cells implanted in vivo.
Surgical procedure
Sixty-four Sprague-Dawleymale rats were used for this study
(Jackson Labs, BarHarbor,ME). All procedureswere approved
by the Animal Studies Committee at Washington University.
Animals were anesthetized using isoflurane, and surgeries were
performed under sterile conditions. The supraspinatus tendon
was cut cleanly from its attachment to the humeral head. A burr
was used to remove existing fibrocartilage at the attachment
footprint. The tendonwas grasped with a modifiedMasonAllen
stitch andpassed throughabone tunnel in thehumeral head.Four
groups were examined: suture repair, acellular scaffold, cellular
scaffold, and cellular BMP2 scaffold.
In the groups with scaffolds, a 5-· 5-mm scaffold was
placed over the repair site, with three suture attachment
points: tendon suture, periosteum distal to the repair site,
and supraspinatus muscle proximal to the repair site (Fig. 1).
Postoperatively, animals were allowed free cage activity.
Animals were randomized to sacrifice timepoints of 14, 28,
or 56 days and assayed for bone morphometry and biome-
chanics (N = 8–10 per group), or histology (N = 2–4 per
group).
Bone morphometry
Samples were scanned in air using microcomputed to-
mography (microCT) (SCANCO mCT40) with 20 mm reso-
lution and 300ms integration time at 45 kV/177 mA. Two
different volumes were analyzed: the scar over the repair
site and the trabecular bone of the humeral head. Scar
characteristics were determined for a 4-mm region near the
tendon-to-bone attachment of the supraspinatus tendon, us-
ing thresholds between 70 and 240. Trabecular bone mor-
phometry was measured in a volume of interest spanning
*2.5mm between the growth plate and the epiphyseal
surface, excluding the cortical bone. Bone morphometry
parameters were calculated using the manufacturer’s soft-
ware (Scanco, Bru¨ttisellen, Switzerland), including bone
volume fraction (BV/TV), bone mineral density (BMD), and
trabecular architecture (thickness [Tb.Th.], number [Tb.N.],
and separation [Tb.S.]).
Mechanical testing and analysis
Uniaxial tensile tests were performed using an Instron
5866 (Instron, Norwood, MA) with custom grips and ana-
lyzed using a custom code written in MATLAB (Math-
works, Natick, MA). Samples were tested at quasi-static
conditions, with a stress relaxation of 5min followed by a
test to failure at a constant strain rate of *0.1%/s. A video
was captured concurrently at 2 fps with a resolution of
3296 · 2474 pixels (VMV-8M; Illunis, Minnetonka, MN).
Engineering stress was calculated by dividing force by the
initial cross-sectional area. Strain was determined as change
in length divided by original length. Length-deformation
data were analyzed to find the stiffness (slope of the linear
region of the force-displacement curve), maximum force,
FIG. 1. A schematic of the human shoulder is shown (A) with the proposed placement of the scaffold (B). In the current
study, the rat supraspinatus tendon was injured and repaired in a similar fashion, with the scaffold placed over the repair site.
The mineralized end was placed over the bone, and the unmineralized was placed over the tendon (mineral content indicated by
green shading in B). Repair sutures are shown in blue. s, supraspinatus muscle; a, acromion; h, humeral head; i, infraspinatus
muscle; b, biceps tendon; images modified from ZygoteBody. Color images available online at www.liebertpub.com/tea
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yield load, and yield deformation. Stress–strain data were
analyzed to find the modulus (slope of the linear region of
the stress–strain curve), strength (maximum stress), yield
stress, yield strain, and toughness.
Histology
Samples selected for histology were demineralized in
ethylenediaminetetraacetic acid and then processed for ei-
ther frozen or paraffin-embedded sections. Samples in the
suture and cellular BMP2 groups were first embedded in
frozen Optimal Cutting Temperature (Tissue-Tek; VWR,
Radnor, PA) to avoid autofluorescence of the paraffin that
would obscure visualization of the BMP2-YFP. Frozen
samples were cryosectioned at 8mm and stained with DAPI
to visualize nuclei. After collecting frozen sections, the
samples were reembedded in paraffin. Samples in the other
two groups were only embedded in paraffin. Paraffin-
embedded samples were sectioned at 8mm and stained with
trichrome, safranin O/fast green, toluidine blue, or hema-
toxylin/eosin. Histologic sections were graded blindly by
Necat Havlioglu for cellularity, inflammation, and tendon-to-
bone healing according to the maturity scale described by
Yokoya et al. (for details on scoring, see legend of Table 1).21
Statistics
Mechanical data were excluded from the final dataset if
grip slippage (9 out of 88 samples) or growth plate failure (7
out of 88 samples) occurred. To compare mechanical and
microCT outcomes, a two-way analysis of variance was
performed on two factors (time: 28, 56 days; and treatment:
suture, acellular, cellular, cellular BMP2), followed by
Fisher’s least-squared difference post hoc tests for time,
treatment, and combined time and treatment effects. Sta-
tistical significance was set at an a level of 0.05. Histologic
scores were not statistically compared due to their semi-
quantitative nature.
Results
BMP2 transduction and in vivo delivery
In vitro culture of BMP2-transduced ASCs showed that
4 mL of the virus was effective for BMP2 production after
24 h (Supplementary Fig. S1A). Expression increased over
the first 3 days of culture and plateaued thereafter (Sup-
plementary Fig. S1B). Based on these results, a 3 day cul-
ture period was chosen between incubation and implantation
in vivo. Delivery of BMP2 to the repair site was validated by
observation of YFP in histologic sections at 28 and 56 days
after surgical repair (Supplementary Fig. S1C).
Histology
The healing interface was dominated by fibrovascular scar
in all groups (Fig. 2 and Supplementary Fig. S2 and Table 1),
as evidenced by high cellularity and vascularity, and poor
collagen orientation and insertion site continuity. The scar
was remodeled over time, as indicated by histologic scores
improving toward normal by 56 days. When comparing the
four groups, the groups that contained a scaffold showed a
notably delayed healing response compared to the suture-
only group. Specifically, scores for cellularity, fraction of
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FIG. 2. Representative histology images from groups at 28 days. For each panel (A) suture group, (B) acellular group, (C)
cellular group, and (D) cellular BMP2 group, high magnification views are shown on the left (trichrome stain) and center
(safranin O stain), and a low magnification view (trichrome) is shown on the right. Rectangles in the low magnification views
denote the positions of the high magnification views. T, tendon; I, insertion; B, bone. Scale bars= 0.5mm in high magnification
panels, 1mm in low magnification panels. Color images available online at www.liebertpub.com/tea
FIG. 3. (A) Representative
3D reconstruction of repaired
attachment. Regions of anal-
ysis are indicated by the
outlined areas. B, bone; I,
insertion; T, tendon. (B) Scar
volume increased from 28 to
56 days in the acellular group
and the suture group was
lower than the acellular and
cellular bone morphogenetic
protein 2 (BMP2) group.
(C) Bone volume over total
volume was decreased in the
cellular BMP2 group com-
pared to other groups at
28 days, but there was no
difference at 56 days. (D)
Trabecular number was sig-
nificantly lower in the 28
days cellular BMP2 group
compared to the other 28
days groups. Bars: mean +
SD, lines over bars indicate
p < 0.05. Color images
available online at www
.liebertpub.com/tea
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cells that were fibroblasts, cell and collagen orientation, and
insertion morphology and continuity were higher (i.e., fur-
ther from normal) in the scaffold-containing groups com-
pared to the suture-only group at 28 days (Table 1). There
were few other apparent differences among groups for the
outcomes measured.
Bone and scar tissue morphology
The cellular BMP2 group had significantly lower trabecular
bone volume and trabecular number, as well as significantly
higher trabecular spacing than the other three treatment groups at
28 days (Fig. 3 andTable 2). The cellular group had significantly
higher trabecular thickness than the acellular group at 56 days;
however, the cellular group also had significantly increased
trabecular spacing than the acellular group at this time point
(Table 1). BMDwas not significantly different among treatment
groups at either timepoints.Whenexamining changes over time,
bone volume and trabecular thickness were significantly in-
creased and the trabecular number was significantly decreased
from 28 to 56 days (Fig. 3 and Table 2). BMD and trabecular
spacing were not significantly changed with time.
Table 2. Trabecular Thickness was Significantly Increased with Both Time and Cells,
Trabecular Spacing was Significantly Increased with Cells
Time point
(days) Group Tb.Th. (lm) Tb.S. (lm)
BMD (mg
HA/ccm)
Ultimate
load (N)
Stiffness
(N/mm)
Ultimate
strain (%)
Toughness
(MPa)
28 Suture 129– 16 331 – 34a 890– 26 21 – 5.5 21.4 – 6.1 34– 14 0.58 – 0.29
Acellular 127– 18 342– 57b 907 – 12 25 – 5.9 18.3 – 3.9 39 – 29 0.70 – 0.37
Cellular 135– 17 364– 46c 902 – 24 25.7 – 9.4 19.4 – 8.9 42 – 11 0.95 – 1.11
Cellular BMP2 130– 9 424– 65a,b,c 907 – 10 19.7 – 5.9 16.3 – 3.1 42 – 16 0.51 – 0.33
56 Suture 147– 26 371 – 68 907– 16 32.3 – 4.9 31.9 – 7.5a 31– 8a 1.00 – 0.7
Acellular 134– 18a 349– 44a 900 – 28 31.1 – 9.4 25.9 – 10 34 – 7b 0.82 – 0.37
Cellular 160– 19a 423– 97a 911 – 13 31.7 – 10 25.6 – 9.4 38 – 11 0.82 – 0.43
Cellular BMP2 145– 21 400– 94 917 – 19 32.6 – 6.6 24.4 – 8.3a 50 – 20a,b 0.89 – 0.31
Stiffness and ultimate load were significantly increased with time. Matching superscript letters indicate groups that are significantly
different from each other ( p < 0.05).
BMD, bone mineral density; Tb.S., trabecular separation; Tb.Th., trabecular thickness.
A
B
C
D
FIG. 4. (A) Average stress–strain curves for 28 days groups and (B) 56 days groups. (C) Ultimate stress (i.e., strength)
increased significantly from 28 to 56 days, and decreased due to BMP2 treatment. (D) Modulus was lower in the BMP2
group compared to the suture group. Modulus was lower in the acellular group compared to the suture group at 56 days.
Bars: mean + SD, lines over bars indicate p < 0.05.
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MicroCT was also used to determine the volume of the
scar tissue at the healing attachment (Fig. 3A). Scar volume
at 28 days was not different among treatment groups. Scar
volume at 56 days was significantly increased in acellular
and cellular BMP2 groups compared to the suture (control)
group. Scar volume was not significantly affected by time.
Mechanical testing
The shapes of the stress–strain curves were similar be-
tween groups at each time point, demonstrating initial toe
regions, followed by linear regions, followed by yield and
postfailure regions (Fig. 4). Strength was significantly de-
creased in the cellular BMP2 group compared to the acel-
lular group at 28 days (Fig. 4). Modulus was significantly
decreased in the cellular BMP2 group compared to the su-
ture and acellular groups at 28 days and compared to the
suture group at 56 days (Fig. 4). Modulus was also signifi-
cantly decreased in the acellular scaffold group compared to
the suture (control) group at 56 days. Stiffness was signifi-
cantly lower in the BMP2 group compared to the suture
group at 56 days. The ultimate strain was significantly
higher in the BMP2 group compared to the suture and
acellular scaffold groups at 56 days. Ultimate load and
toughness were not significantly different among treatment
groups (Table 2). Structural (stiffness and ultimate load) and
material properties (modulus and strength) were signifi-
cantly increased with time (Fig. 4 and Table 2). Ultimate
strain and toughness were not affected by time (Table 2).
Discussion
A nanofiber scaffold with a gradient in mineral was used
to deliver cells to the rotator cuff repair site in an animal
model. This approach attempted to address two features of
failed rotator cuff tendon-to-bone healing: loss of bone and
disorganized (scar) matrix formation at the interface. De-
spite the use of a scaffold mimicking the mineral gradient
and aligned nature of the native tendon-to-bone attachment,
the repair was dominated by scar formation. Furthermore,
the use of cells transduced with the osteogenic factor BMP2
led to impaired healing, as demonstrated by decreased tra-
becular bone and decreased mechanical properties.
Healing after an acute rotator cuff injury and repair pro-
gresses from an early inflammatory phase (on the order of
days) to a proliferative and remodeling phase (on the order
of weeks), leading to disorganized scar tissue formation
composed of types I and III collagen.3 Although a large
volume of scar is deposited at the repair site during healing,
the mechanical properties of the attachment remain
dramatically lower than the healthy attachment.3,7 The scar-
mediated response is driven by fibroblasts, presumably re-
cruited by inflammatory cytokines.22 Despite the existence
of tendon stem cells,23 the tendon healing response is scar
mediated rather than regenerative. In the current study,
ASCs were delivered to the repair site in an effort to pro-
mote a regenerative response (i.e., recreation of the native
attachment site structure) rather than the natural fibrovas-
cular scar response. Mesenchymal stem cells have been
shown to modulate inflammation and differentiate down the
multiple lineages, including the tendon fibroblasts, chon-
drocytes, and osteoblasts found at the healthy tendon-to-
bone attachment.19,20,24 However, delivery of ASCs was
ineffective in improving the repair in the current study. The
lack of effect may have been due to a low number of im-
planted cells relative to the numbers of cells that naturally
fill the repair site. Moreover, the implanted cells were
placed as a patch over the repair site, and therefore were not
directly at the interface between the healing tendon and
bone.
The scaffold had a negative effect on healing, as dem-
onstrated by decreased mechanical properties. Scaffolds of
various types have been used for tissue engineering of the
enthesis, including natural materials such as collagen, fibrin,
and polymeric materials such as PLGA and poly-lactic
acid.25–27 In vitro studies have shown great promise for the
use of electrospun polymer scaffolds in tendon-to-bone
tissue engineering applications.28,29 Moffat et al. showed
that aligned nanofiber scaffolds drove mesenchymal stem
cells toward a tendon lineage, ideal for rotator cuff repair.
Liu et al. showed that a gradient in mineral promoted a
gradient in cell phenotype, with osteoblastic differentiation
correlating with mineral content.15 However, few studies
have applied these in vitro results to a clinically relevant
in vivo animal model. In the current study, we found that the
native fibrovascular response overwhelmed any benefit of
the implanted cells or the aligned nanofibers with a gradient
in mineral. Indeed, the scaffold itself impaired the healing
process, perhaps due to negative effects of PLGA degra-
dation products (e.g., an acidic local environment can po-
tentiate bone loss).30 A histologic assessment indicated that
groups with a scaffold had maturity scores further from
normal at 28 days than the group without a scaffold. This
corresponds well with the observed decrease in modulus in
scaffold-containing groups, since the histology indicated a
muted remodeling response in those groups.
Although it is a potent osteogenic agent in most cases,
BMP2 has also been shown to cause bone loss in certain
cases.31–33 The delivery of BMP2 through adenoviral gene
transfer in the current study led to loss of bone and
decreased mechanical properties of the healing tendon-to-
bone attachment. Based on BMP2-YFP expression pat-
terns, in vitro and in vivo studies demonstrated prolonged
expression of BMP2. This sustained expression of BMP2
may have led to a negative osteoblast–osteoclast feedback
loop and increased bone resorption. BMP2 appears to
function in both osteoblastogenesis and osteoclastogenesis,
complicating its role as a therapeutic osteogenic growth
factor.31,32 A previous study using recombinant BMP2 in a
canine flexor tendon-to-bone repair model also showed an
increased resorption and decreased mechanical properties
with the use of the growth factor.33 As osteoclasts are
prominent at the healing tendon-to-bone interface and
BMP2-stimulated osteoclastogenesis by osteoblast activa-
tion, the use of BMP2 for enhanced tendon-to-bone repair
is not advised. These results are in contrast to previous
studies demonstrating an increased bone formation with
BMP2 treatment. For example, delivery of recombinant
BMP2 led to the improved healing of a tendon graft in a
bone tunnel in an animal model of anterior cruciate liga-
ment reconstruction.34 This and other positive results using
BMP2 imply that the context, delivery method, and dosage
of BMP2 may dictate its efficacy. In the current study,
BMP2 was delivered using a gene delivery approach,
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leading to a sustained, but uncontrolled dosage. It is pos-
sible that a different dose of BMP2 may have been more
effective in improving tendon-to-bone healing.
There were a number of limitations to the study. First, an
empty viral vector control group was not included in the
study design. BMP2 was delivered using a viral vector,
which could potentially cause an immune reaction. How-
ever, the cells were transduced in vitro, before implantation,
and did not carry adenovirus after transfer. These cells did
carry truncated adenovirus genome DNA at implantation,
but the genome DNA is not equivalent to virus since the
recombinant virus DNA will not amplify anymore. There-
fore, it was not expected that the viral delivery method
would have any negative effects on healing.
Although the mineral gradient of the scaffold mimics the
trend found in the natural insertion, the scale of its length is
different. The tendon transitions to bone over hundreds of
microns, but the mineral gradient in rodents only spans
*20 mm.13 In the current study, the length of the mineral
gradient was an order-of-magnitude longer than the natural
mineral gradient. This increased length of the mineral gra-
dient may therefore have been ineffective for enhancing the
tendon-to-bone repair strength.
In summary, the current study revealed a number of
critical considerations for enhancing tendon-to-bone healing
using regenerative medicine approaches: (i) regenerative
strategies can be overwhelmed by the natural scar-mediated
response, (ii) BMP2 is not an effective growth factor for
improving tendon-to-bone healing, and (iii) scaffolding
material may negatively affect healing.
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